SOX9 and neoplasm: The combination of nanotechnology‐based PDT with siRNA‐mediated silencing of immune‐evasion molecules such as SOX9 enhances photosensitizer delivery efficiency and remodels the immune microenvironment, restoring DC and CD8+ T‐cell function and substantially improving tumor‐specific immune responses.